^
BIOMARKER:

CDKN2A mutation + TP53 mutation

i
Other names: CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf, Cyclin-dependent kinase inhibitor 2A, TP53, Tumor Protein P53, Cellular Tumor Antigen P53, Phosphoprotein P53, Tumor Protein P53, Antigen NY-CO-13, Transformation-Related Protein 53, Mutant Tumor Protein 53, P53 Tumor Suppressor, Tumor Suppressor P53, Tumor Protein 53, BMFS5, TRP53, BCC7, LFS1
Entrez ID:
CDKN2A mutation + TP53 mutation
Small Cell Lung Cancer
AZD1775
Sensitive: C2 – Inclusion Criteria
CDKN2A mutation + TP53 mutation
NSCLC
Immunotherapy
Sensitive: C3 – Early Trials